Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine is a synthetic small molecule known primarily as an experimental inhibitor of mitogen-activated protein kinase (MAPK) pathways. It is most commonly referred to as "ERK inhibitor II" or by its code name "FR180204". The compound selectively inhibits extracellular signal-regulated kinases (ERK), specifically mitogen-activated protein kinase 1 and mitogen-activated protein kinase 6. These kinases are key components of the MAPK/ERK signaling pathway involved in cell proliferation and survival. The compound has been used in research settings to study ERK-dependent cellular processes but has not advanced into clinical development or received regulatory approval for any indication[2][5][1].
- Other names
- DTXCID70644238DTXCID-70644238DTXCID 70644238dtxsid30693489dtxsid-30693489dtxsid 30693489CHEMBL259551CHEMBL-259551CHEMBL 259551865362-74-94C7X7GV82C
02
Targets
MAPK6 (Mitogen-activated protein kinase 6)MAPK3 (Mitogen-activated protein kinase 1)
Beyond the preview
Go deeper on 5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridazin-3-amine.